Bank stocks saw a significant jump on Friday, propelling the Nifty Bank index to a one-month peak. This surge followed news of a potential ...

Nifty is trading in a consolidation zone between 23,200 and 24,050. Analysts suggest buying on dips with a target of 23,900. Key sectors li...

Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...

Graphite India Ltd. reached a new record high in May 2026, with chart patterns indicating further potential gains. Experts suggest short-te...

Gujarat Fluorochemicals Ltd has broken a 15-month falling trendline resistance, signaling a positive outlook for bulls. Experts suggest med...

Crompton Ltd shows signs of a bullish reversal, with a double bottom pattern and a strong daily candle above its 200-day EMA. Increased tra...

Oberoi Realty's shares, currently at Rs 1,592, are showing bullish reversal signs with Double Bottom and Descending Triangle patterns. A su...

Uno Minda Ltd, an aerospace industry player, shows potential for a price surge. Experts suggest a buying opportunity for high-risk traders ...

HDFC Life Insurance is gaining momentum with a Double Bottom pattern on daily charts. A breakout above Rs 730 may propel the stock to Rs 80...

Nifty shows signs of an upside bounce, forming a double bottom pattern around 24,700 levels. A move above 25,000 could lead to 25,400-25,50...

Bayer Cropscience Ltd, an agrochemical stock, exhibits strong bullish momentum with potential for record highs above 7000 levels, supported...

Syngene International Ltd, a pharma stock, fell 15% from its September 2023 high but recovered after a Double Bottom formation. Short-term ...

A break below the 11,500 mark should make Nifty retest the 11,430-60 levels.

Double bottom is formed at the bottom and indicates the end of a falling market.

Since the market has reversed from an oversold territory, many oversold stocks are still likely to bounce back sharply, well supported by s...

On the lower side I would say 9,800-9,850 is a very crucial support.

Investors with a long-term investment horizon can pick pharma stocks.